The annual number of drug overdose deaths in the United States involving opioids has more than quadrupled since 1999, a new report from the Congressional Research Service notes.
“CDC estimates that in 2016, more than 63,000 people died from a drug overdose, and more than 42,000 of these deaths involved prescription or illicit opioids.” See The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action, June 5, 2018.
Other new and updated reports from the Congressional Research Service include the following.
Increase in Illicit Fentanyl Overdose Deaths, CRS Insight, June 6, 2018
Capital Markets, Securities Offerings, and Related Policy Issues, June 8, 2018
The Rise and Decline of the Alien Tort Statute, CRS Legal Sidebar, June 6, 2018
Intelligence Planning, Programming, Budgeting and Evaluation Process (IPPBE), CRS In Focus, May 30, 2018
Recent Trends in Active-Duty Military Deaths, CRS In Focus, June 1, 2018
Expedited Citizenship through Military Service, CRS In Focus, May 11, 2018
Egypt: Background and U.S. Relations, updated June 7, 2018
Department of State, Foreign Operations and Related Programs: FY2019 Budget and Appropriations, updated June 8, 2018
How to Develop and Write a Grant Proposal, updated June 7, 2018
The United States needs a strategic investment fund (SIF) to shepherd promising technologies in nationally vital sectors through the valley of death.
Standardizing support for Accessibility & Accommodations in federally funded research efforts would open opportunities for disabled scientists and their research programs.
The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.
Increasingly, U.S. national security priorities depend heavily on bolstering the energy security of key allies, including developing and emerging economies. But U.S. capacity to deliver this investment is hamstrung by critical gaps in approach, capability, and tools.